INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
HP
Hung PriscillaDirector
VEEVVEEVA SYSTEMS INC
Open-market sale
SELL$196K
750 sh
Sep 9, 2026Sep 11, 2026
Page 124 of 481
← PrevNext →
traded Sep 9, 2026
+2d
SEC Form 4

Evidence

24
TH
Toro 18 Holdings LlcSee Explanation of Responses
UEICUNIVERSAL ELECTRONICS INC
Open-market sale
SELL$114K
24.5K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

24
RM
Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$1.19M
3,647 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

24
BR
Bridwell Mark REVP, GC and Secretary
RYNRAYONIER INC
Open-market sale
SELL$107K
5,318 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

23
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$138K
1,416 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

23
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
31.4K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$108K
1,285 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

22
ES
Evans Katie SeitzSee Remarks
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$336K
14.0K sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

21
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.15M
24.4K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

21
RM
Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$429K
1,300 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

21
RM
Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$260K
800 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

21
CM
Craddock John Mitchell Jr.Chief Operating Officer
SBSISOUTHSIDE BANCSHARES INC
Open-market sale
SELL$13K
415 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

21
JJ
Jenkins JerrySVP, CHRO
GETYGetty Images Holdings, Inc.
Open-market sale
SELL$588
2,558 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$285K
1,360 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,920 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$914K
4,400 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$584K
2,800 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$303K
1,431 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$303K
1,440 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$418K
2,000 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

18
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$652K
7,171 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

17
KS
Kerr Michael SGeneral Counsel
QTWOQ2 Holdings, Inc.
Open-market sale
SELL$39K
636 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
360 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$93K
440 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

16
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$898K
13.8K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
1,160 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
1,169 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
BT
Briggs TeresaDirector
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$35K
548 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
920 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

15
TP
Tak Paul PeterDirector, Chief Executive Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$621K
59.4K sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

15
MS
Musunuri ShankarDirector, Chief Executive Officer
OCGNOcugen, Inc.
Open-market sale · 10b5-1 plan
SELL$525K
468.7K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

14
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$179K
10.2K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
1,206 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
120 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
80 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,630 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
1,100 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.97M
20.5K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K